Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

Name: Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs
Start: 2026-03-15T11:10:00-04:00
End: 2026-03-15T11:55:00-04:00
Location: Royal Ballroom 1, Miami, FL

General Session

Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

45 min

Sunday, March 15, 2026

11:10 AM - 11:55 AM

Supported by educational grants from AstraZeneca and Stemline Therapeutics Inc, a Menarini Company.

Presenter
- Sara Nunnery MD, MSCI

Room
- Royal Ballroom 1

Breast Cancers